Synthesis of thiazolidin-4-ones and thiazinan-4-ones from 1-(2-aminoethyl)pyrrolidine as acetylcholinesterase inhibitors

References

• Precoma JM, Berumen LC, Padilla K, Alcocer GG. Therapies for prevention and treatment of alzheimer's disease. BioMed Res Int ID 2016;2016:2589276–17.
   PubMed Web of Science ®Google Scholar
• Ocampo AB, Lopera F. Amyloid-beta immunotherapy: the hope for Alzheimer disease? Colomb Med 2016;47:203–12.
   PubMed Web of Science ®Google Scholar
• Costa JS, Lopes JPB, Russowsky D, et al. Synthesis of tacrine-lophine hybrids via one-pot four component reaction and biological evaluation as acetyl- and butyrylcholinesterase inhibitors. Eur J Med Chem 2013;62:556–63.
   PubMed Web of Science ®Google Scholar
• Vieira THF, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer's disease: targeting the cholinergic system. Curr Neuropharmacol 2016;14:101–15.
   PubMed Web of Science ®Google Scholar
• Kumar A, Nisha CM, Silakari C, et al. Current and novel therapeutic molecules and targets in Alzheimer's disease. J Formos Med Assoc 2016;15:3–10.
   Web of Science ®Google Scholar
• Kumar KSS, Mohan CD, Jagadish S, et al. Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of arecoline, 4-thiazolidinone- and piperidine- based conjugates. Asian J Pharm Clin Res 2015;8:142–8.
   Google Scholar
• Wu WY, Dai YC, Li NG, et al. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease. J Enzyme Inhib Med Chem 2017;32:572–87.
   PubMed Web of Science ®Google Scholar
• Guzior N, Wi.eckowska A, Panek D, Malawska B. Recent development of multifunctional agents as potential drug candidates for the treatment of alzheimer’s disease. Curr Med Chem 2014;22:373–404.
   Web of Science ®Google Scholar
• Dey A, Bhattacharya R, Mukherjee A, Pandey DK. Natural products against Alzheimer's disease: pharmacotherapeutics and biotechnological interventions. Biotechnol Adv 2017;35:178–216.
   PubMed Web of Science ®Google Scholar
• Vitaku E, Smith DT, Njardarson JT. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J Med Chem 2014;57:10257–74.
   PubMed Web of Science ®Google Scholar
• Bosenbecker J, Bareño VDO, Difabio R, et al. Synthesis and antioxidant activity of 3-(pyridin-2-yl,ethyl)-1,3-thiazinan(thiazolidin)-4-ones. J Biochem Mol Toxic 2014;28:425–32.
   PubMed Web of Science ®Google Scholar
• Bielenica A, Sanna G, Madeddu S, et al. New thiourea and 1,3-thiazolidin-4-one derivatives effective on the HIV-1 virus. Chem Biol Drug Des 2017;90:883–91.
   PubMed Web of Science ®Google Scholar
• Ansari MF, Idrees D, Hassan MI, et al. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: targeting human carbonic anhydrase IX. Eur J Med Chem 2018;144:544–56.
   PubMed Web of Science ®Google Scholar
• da Silva DS, da Silva CEH, Soares MSP, et al. Thiazolidin-4-ones from 4-(methylthio)benzaldehyde and 4-(methylsulfonyl)benzaldehyde: synthesis, antiglioma activity and cytotoxicity. Eur J Med Chem 2016;124:574–82.
   PubMed Web of Science ®Google Scholar
• Gouvêa DP, Vasconcellos FA, Berwaldt GA, et al. 2-Aryl-3-(2-morpholinoethyl)thiazolidin-4-ones: synthesis, anti-inflammatory in vivo, cytotoxicity in vitro and molecular docking studies. Eur J Med Chem 2016;118:259–65.
   PubMed Web of Science ®Google Scholar
• Patel NB, Patel MD. Synthesis and evaluation of antibacterial and antifungal activities of 4-thiazolidinones and 2-azetidinones derivatives from chalcone. Med Chem Res 2017;26:1772–83.
   Web of Science ®Google Scholar
• Raza S, Srivastava SP, Srivastava DS, et al. Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents. Eur J Med Chem 2013;63:611–20.
   PubMed Web of Science ®Google Scholar
• Solomon VR, Pundir S, Le HT, Lee H. Design and synthesis of novel quinacrine-[1,3]-thiazinan-4-one hybrids for their anti-breast cancer activity. Eur J Med Chem 2018;143:1028–38.
   PubMed Web of Science ®Google Scholar
• Kumawat MK, Singh UP, Singh B, et al. Synthesis and antimalarial activity evaluation of 3-(3-(7-chloroquinolin-4-ylamino)propyl)-1,3-thiazinan-4-one derivatives. Arab J Chem 2016;9:643–7.
   Web of Science ®Google Scholar
• Pramanik S, Kumar A. Synthesis of various 3-(6-substituted-3-hydroxy-2,2-dimethyl-3,4-dihydro-2H-benzopyran-4-yl)-2-substituted-1,3-thiazinan-4-ones for antihypertensive activity. World J Pharm Pharm Sci 2015;4:888–901.
   Google Scholar
• Elenich IP, Rassukana YV, Khomutnik YY, et al. Synthesis, the antioxidant and antibacterial activity of fluoroalkyl substituted thiazolidinones and thiazinanones incorporating an aminophosphonate or aminocarboxylate fragment. Zh Org Farm Khim 2014;12:45–8.
   Google Scholar
• Tripathi AC, Gupta SJ, Fatima GN, et al. 4-Thiazolidinones: the advances continue. Eur J Med Chem 2014;24:52–77.
   Web of Science ®Google Scholar
• Neves AHS, da Silva DS, Siqueira GM, et al. The antinociceptive evaluation of 2,3-substituted-1,3-thiazolidin-4-ones through thermal stimulation in mice. Med Chem Res 2018;27:186–93.
   Web of Science ®Google Scholar
• Neves AM, Campos Junir JC, Gouvêa DP, et al. Synthesis of thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone. J Het Chem 2019;56:251–9.
   Web of Science ®Google Scholar
• Zehetmeyr FK, da Silva M, Pereira KM, et al. Ovicidal in vitro activity of 2-aryl-3-(2-morpholinoethyl)thiazolidin-4-ones and 2-aryl-3-(3-morpholino-propyl)thiazolidin-4-ones against Fasciola hepatica (Linnaeus, 1758). Exp Parasitol 2018;192:60–4.
   PubMed Web of Science ®Google Scholar
• Drawanz BB, Zimmer GC, Rodrigues LV, et al. 5,6,7,8-Tetrahydronaphthalen-1-amine as precursor for thiazolidinones and benzothiazepinones: synthesis and atropisomeric relationship. Synthesis 2017;49:5167–75.
   Web of Science ®Google Scholar
• Berwaldt GA, Gouvêa DP, da Silva DS, et al. Synthesis and biological evaluation of benzothiazin-4-ones: a possible new class of acetylcholinesterase inhibitors. J Enz Inhibit Med Chem 2019;34:197–203.
   PubMed Web of Science ®Google Scholar
• Elmann GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 1976;72:248–54.
   PubMed Web of Science ®Google Scholar
• Gottfried C, Valentim L, Salbego C, et al. Regulation of protein phosphorylation in astrocyte cultures by external calcium ions: specific effects on the phosphorylation of glial fibrillary acidic protein (GFAP), vimentin and heat shock protein 27 (HSP27). Brain Res 1999;833:142–9.
   PubMed Web of Science ®Google Scholar
• Saxena M, Dubey R. Target enzyme in alzheimer's disease: acetylcholinesterase inhibitors. Curr Top Med Chem 2019;19:264–75.
   PubMed Web of Science ®Google Scholar
• Jo T, Nho K, Saykin AJ. Deep learning in alzheimer's disease: diagnostic classification and prognostic prediction using neuroimaging data. Front Aging Neurosci 2019;11:220.
   PubMed Web of Science ®Google Scholar
• Tiwari S, Atluri V, Kaushik A, et al. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 2019;14:5541–54.
   PubMed Web of Science ®Google Scholar
• Briggs R, Kennelly SP, O'Neill D. Drug treatments in Alzheimer's disease. Clin Med (Lond) 2016;16:247–53.
   PubMed Web of Science ®Google Scholar
• Silman I, Sussman JL. Recent developments in structural studies on acetylcholinesterase. J Neurochem 2017;2:19–25.
   Web of Science ®Google Scholar
• Wiesner J, Kříž Z, Kuča K, et al. Acetylcholinesterases-the structural similarities and differences. J Enzyme Inhib Med Chem 2007;22:417–24.
   PubMed Web of Science ®Google Scholar
• Ozadali K, Ozkannli F, Erol D, et al. Synthesis and biological activities of some thiazolidin-4-ones. Arzneimittelforschung 2006;56:678–81.
   PubMed Web of Science ®Google Scholar
• Nam SO, Park DH, Lee YH, et al. Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors. Bioorg Med Chem 2014;22:1262–7.
   PubMed Web of Science ®Google Scholar
• Tang H, Ning FX, Wei YB, et al. Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors. Bioorg Med Chem Lett 2007;17:3765–8.
   PubMed Web of Science ®Google Scholar